Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FU7D8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,401
Award facts
- Contract value 100% obligated
- $16,400.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,400.67 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) with a completion date of June 2, 2025. This firm fixed-price contract, awarded on May 30, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical and medical supply deliveries. The company's primary federal customer is the DLA Medical Supply Chain, which procures medications and medical commodities to support the Defense Health Agency and other government healthcare systems. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains for military and veteran healthcare needs. The firm fixed-price delivery order structure and competitive award process demonstrate AmerisourceBergen's capability to meet federal procurement requirements while supporting critical medical supply chains for defense operations.
Quick answers
Who was awarded contract SPE2DB25FU7D8?
SPE2DB25FU7D8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FU7D8 worth?
The government has obligated $16,401 on SPE2DB25FU7D8.
Is contract SPE2DB25FU7D8 an order under another contract?
Yes. SPE2DB25FU7D8 is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FU7D8 competed?
The extent of competition for SPE2DB25FU7D8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award